Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Non-cash Items: 2023-2024

Historic Non-cash Items for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Dec 2024 value amounting to $298.0 million.

  • NewAmsterdam Pharma Co N.V's Non-cash Items rose 29.16% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 29.16%. This contributed to the annual value of $298.0 million for FY2024, which is 486.62% up from last year.
  • NewAmsterdam Pharma Co N.V's Non-cash Items amounted to $298.0 million in FY2024, which was up 486.62% from $50.8 million recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's 5-year Non-cash Items high stood at $298.0 million for FY2024, and its period low was $50.8 million during FY2023.
  • Its 2-year average for Non-cash Items is $174.4 million, with a median of $174.4 million in 2023.
  • Data for NewAmsterdam Pharma Co N.V's Non-cash Items shows a peak YoY soared of 486.62% (in 2024) over the last 5 years.
  • Over the past 2 years, NewAmsterdam Pharma Co N.V's Non-cash Items (Yearly) stood at $50.8 million in 2023, then skyrocketed by 486.62% to $298.0 million in 2024.